Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642434 · ClinicalTrials.gov registry record · Phase 4
Comparison of Blood Pressure Medications on Metabolism
A Phase 4 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT00642434 is a Phase 4 study that has completed, run by University of New Mexico. The registered enrollment target is 22 participants.
The verdict
NCT00642434, a Phase 4 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there are differences, (benefits) between carvedilol and metoprolol in the treatment of HTN in patients with type 2 diabetes. Specifically we will be looking at differences in blood pressure and blood sugar control, endothelial function, inflammation, oxidative stress and coagulation. Subjects will be randomized to one of the two beta-blockers and followed for 5 months. Each subject will undergo 4 inpatient studies where an oral glucose tolerance test will be done, Inflammatory and oxidative stress markers will be measured. Endothelial function will be measured using brachial artery ultrasound and laser skin Doppler
Interventions
- DRUG metoprolol
- DRUG carvedilol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00642434
The ClinicalTrials.gov registry entry for NCT00642434 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which metoprolol is the first listed.
NCT00642434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00642434 about?
NCT00642434 is a clinical study titled "Comparison of Blood Pressure Medications on Metabolism". The purpose of this study is to determine if there are differences, (benefits) between carvedilol and metoprolol in the treatment of HTN in patients with type 2 diabetes. Specifically we will be looking at differences in blood pressure and blood sugar control, endothelial function, inflammation, oxi...
What is the current status of trial NCT00642434?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2004-01. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00642434?
The interventions under investigation include: metoprolol (DRUG), carvedilol (DRUG).
Who is sponsoring clinical trial NCT00642434?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.